GENE ONLINE|News &
Opinion
Blog

2026-04-08|

New Technique CIPHER-seq Tracks RNA and Protein Activity in Single Immune Cells

by GOAI
Share To

A new single-cell sequencing technique is providing researchers with an unprecedented view of immune cell behavior, uncovering previously unseen gaps in immune signaling. The method, called CIPHER-seq, allows scientists to simultaneously measure RNA and protein expression within individual immune cells. This dual measurement capability offers a detailed and dynamic perspective on the temporal relationship between genetic instructions and protein activity.

CIPHER-seq represents a significant advancement in single-cell technology by enabling researchers to observe the interplay between RNA transcription and protein translation within the same cell. This approach provides insights into how immune cells respond to various stimuli over time, revealing complex patterns that were not detectable using previous methods. By capturing both RNA and protein data concurrently, scientists can better understand the mechanisms underlying immune responses and cellular communication.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
Japanese Researchers Identify Stem Cell Dynamics in Vocal Fold Tissue Maintenance and Repair
2026-04-16
Study Identifies Active Role of Skin Cells in Rabies Virus Replication and Transmission
2026-04-16
Contractor Fatality Halts Operations at ATEX Resources’ Valeriano Project in Chile
2026-04-15
Dual Inhibition of xCT and GGCT Induces Ferroptosis in Glioblastoma Cells
2026-04-15
Researchers Develop Method to Convert Ketones into Saturated Heterocycles for Pharmaceutical Applications
2026-04-15
Naturally Occurring Compounds Luteolin, Naringenin, and Scutellarin Identified as Potential Inhibitors of Breast Cancer-Linked Enzymes HDAC4 and HDAC8
2026-04-15
Scroll to Top